Viewing Study NCT06150157


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2026-02-20 @ 4:47 PM
Study NCT ID: NCT06150157
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-11-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloproliferative Disorders View
None Essential Thrombocythemia View
None Neoplasms View
None Myelofibrosis View
Keywords: